Traitements concernés :
Abemaciclib (Verzenios), Abiraterone (Zytiga), Afatinib (Giotrif), Alectinib (Alecensa), Altretamine (Hexalen), Anagrelide (Agrylin), Anastrozole (Arimidex), Apalutamide (Erleada), Axitinib (Inlyta), Bexarotène (Targretin), Bicalutamide (Casodex), Binimectinib (Mektovi), Bosutinib (Bosulif), Brigatinib (Alunbrig), Busulfan (Myleran), Cabozantinib (Cabometyx), Capécitabine (Xeloda), Ceritinib (Zykadia), Chlorambucil (Leukeran), Cobimetinib + Vemur-fénib (Cotellic + Zelboraf), Crizotinib (Xalkori), Cyclophosphamide (Endoxan), Dabrafénib (Tafinlar), Dasatinib (Sprycel), Enzalutamide (Xtandi), Erlotinib (Tarceva), Estramustine (Emcyt), Étoposide (Vepesid), Évérolimus (Afinitor), Exémestane (Aromasin), Fludarabine (Fludara), Géfitinib (Iressa), Hydroxycarbamide (Hydrea), Ibrutinib (Imbruvica), Idarubicine (Idamycin), Idelalisib (Zydelig), Imatinib (Glivec), Ixazomib (Ninlaro), Lapatinib (Tyverb), Lenalidomide (Revlimid), Lenvatinib (Lenvima), Létrozole (Femara), Lorlatinib (Lorbrena), Megestrol (Megace), Melphalan (Alkeran), Mercaptopurine (Purinethol), Methotrexate (Rheumatrex, Trexall), Nilotinib (Tasigna), Nilutamide (Anandron), Nintédanib (Ofev), Niraparib (Zejula), Olaparib (Lynparza), Osimertinib (Tagrisso), Palbociclib (Ibrance), Pazopanib (Votrient), Pipobroman (Vercyte), Pomalidomide (Pomalyst), Ponatinib (Iclusig), Procarbazine (Matulane), Régorafenib (Stivarga), Ribociclib (Kisqali), Rucaparib (Rubraca), Ruxolitinib (Jakavi), Sonidegib (Odomzo), Sorafenib (Nexavar), Sunitinib (Sutent), Tamoxifène (Nolvadex), Thalidomide (Thalomid), Topotécan (Hycamtin), Torémifène (Fareston), Trametinib (Mekinist), Trifluridine/Tipiracine (Lonsurf), Vandétanib (Caprelsa), Vemurafénib (Zelboraf), Venetoclax (Venclyxto), Vinorelbine (Navelbine), Vismodegib (Erivedge).
